Author:
Côté Julie,Kotb Rami,Bergstrom Debra J.,LeBlanc Richard,Mian Hira S.,Othman Ibraheem,Louzada Martha L.
Funder
GlaxoSmithKline Inc
Hamilton Health Sciences Foundation
GlaxoSmithKline
Subject
Cancer Research,Oncology,Hematology
Reference111 articles.
1. Surveillance, epidemiology and end results (SEER) Cancer Stat Facts: Myeloma. National Cancer Institute. Bethesda, MD. Available at: https://seer.cancer.gov/statfacts/html/mulmy.html Accessed: February 8, 2022.
2. American Society of Clinical Oncology (ASCO). ASCO Guidelines Methodology Manual. Available at: https://www.asco.org/sites/new-www.asco.org/files/content-files/practice-and-guidelines/documents/2019-Guidelines-Methodology-Manual.pdf. Accessed: March 31, 2022.
3. Autologous stem cell transplant in older patients (age ≥ 65) with newly diagnosed multiple myeloma: A systematic review and meta-analysis;Mian;J Geriatr Oncol,2020
4. Autologous stem cell transplantation is safe and effective for fit older myeloma patients: exploratory results from the Myeloma XI trial;Pawlyn;Haematologica,2022
5. Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma;Munshi;Cancer,2020